Too Many Biotechnology Bargains: Which Is The Best Bet For 2013?
There are many articles on Seeking Alpha on the biotechnology companies -- Vivus Inc. (VVUS), Amgen Inc. (AMGN), Novo Nordisk A/S (NVO), Gilead Sciences Inc. (GILD) and Celgene Corporation (CELG). They have a very similar story to tell. They are selling at relative price multiples that are below or close to the industry average. However, the more important question is which is the best bargain among the five stocks? There is limited analysis comparing the biotechnology companies on similar parameters, even though many analysts are making separate arguments built along the same lines.
In this article, we will look at some valuation measures, historical performance indicators, and forward growth estimates to see if we can determine which of these companies could be a profitable investment in 2013.
Read more: http://seekingalpha.com/article/1207281-too-many-biotechnology-bargains-which-is-the-best-bet-for-2013
| < Prev | Next > |
|---|
